Profile
Tetsuro Maeda served as the President and Representative Director of Denka Seiken Co., Ltd.
and as the Representative Director, EVP, Head-R&D of Denka Co., Ltd.
He graduated from Waseda University with a graduate degree in 1977.
Former positions of Tetsuro Maeda
Companies | Position | End |
---|---|---|
Denka Seiken Co., Ltd.
Denka Seiken Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Denka Seiken started out as a manufacturer of vaccines for human use. Later, they became involved with diagnostic reagents and expanded the scope of their business activities to meet the needs of their customers, offering product lines, service, and knowledge to hospitals and clinics. Denka Seiken has established itself as a manufacturer of vaccines and diagnostic reagents. Denka Seiken is engaged in research and development in such fields as bacteriology and virology, immunochemistry, clinical chemistry and food-related diagnostic reagents, in addition to vaccines against influenza, DPT, and other illnesses. | President | - |
DENKA COMPANY LIMITED | Chief Tech/Sci/R&D Officer | 2013-03-31 |
Training of Tetsuro Maeda
Waseda University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DENKA COMPANY LIMITED | Process Industries |
Private companies | 1 |
---|---|
Denka Seiken Co., Ltd.
Denka Seiken Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Denka Seiken started out as a manufacturer of vaccines for human use. Later, they became involved with diagnostic reagents and expanded the scope of their business activities to meet the needs of their customers, offering product lines, service, and knowledge to hospitals and clinics. Denka Seiken has established itself as a manufacturer of vaccines and diagnostic reagents. Denka Seiken is engaged in research and development in such fields as bacteriology and virology, immunochemistry, clinical chemistry and food-related diagnostic reagents, in addition to vaccines against influenza, DPT, and other illnesses. | Commercial Services |
- Stock Market
- Insiders
- Tetsuro Maeda